Danaher has gotten torched over the last six months - since December 2025, its stock price has dropped 21.2% to $178.42 per share. This may have investors wondering how to approach the situation.
DHR closes its $9.9B Masimo acquisition, adding AI-enabled patient-monitoring and sensor technologies to expand diagnostics solutions.
Investors need to pay close attention to DHR stock based on the movements in the options market lately.
Danaher (NYSE:DHR) is a stock built to own for 25 years because it supplies the irreplaceable plumbing of modern biologic drug manufacturing, and that position compounds quietly through every market c
Danaher is seeing strong Biotechnology growth as bioprocessing demand rises, with equipment orders up more than 30% and core revenue gains expected in 2026.
Danaher Corporation ( NYSE:DHR ) saw a double-digit share price rise of over 10% in the past couple of months on the...
SpaceX initiated, Intel upgraded: Wall Street's top analyst calls
Pre-Market Stock Futures: Futures are trading higher after a dreadful day on Wall Street, when all the major indices traded lower, and we saw the same pattern that has developed over the last week. Th
View interactive chart, options flow, and AI analysis for DHR on Zorveq Finance.
Open DHR Chart & Analysis →